Halide Bond Assisted Double Desymmetrization of Meso-Dicarboxylic Acids with Symmetrical Olefins via Asymmetric Halogenation. [PDF]
Zhang Q, Wang H, Tse YS, Yeung YY.
europepmc +1 more source
Venetoclax-based therapy in high-risk patients with relapsed/refractory multiple myeloma harboring t(11;14): a case report and review of the literature. [PDF]
Yin J, Zhou X, Zhong Y.
europepmc +1 more source
Efficacy analysis of CAR-T cells against CD123-positive malignant tumors and exploration of the feasibility of combination therapy with venetoclax. [PDF]
Zhang M +8 more
europepmc +1 more source
Dimerisation of aryl-substituted bicyclobutanes (BCBs): revealing a new mode of 1,3-dipolar background reactivity. [PDF]
George M +4 more
europepmc +1 more source
Repeated courses of sequential venetoclax and donor lymphocyte infusions in a patient with relapsed high-risk myelodysplasia following allogeneic stem cell transplantation: a case report. [PDF]
Gigli F +9 more
europepmc +1 more source
The impact of venetoclax treatment duration on efficacy and hematologic toxicity in acute myeloid leukemia: a systematic review and meta-analysis. [PDF]
Pan Y +7 more
europepmc +1 more source
Hypomethylating agents plus venetoclax in younger acute myeloid leukemia: Meta-analysis of a shifting treatment paradigm. [PDF]
Perrone S +3 more
europepmc +1 more source
A Nomogram Prediction Model and Scoring System for Resistance in Acute Myeloid Leukemia Patients Treated with Venetoclax Combined with Hypomethylating Agents. [PDF]
Fan Q +6 more
europepmc +1 more source
Investigations Into the Metabolism and Elimination of Tesofensine in Human Urine. [PDF]
Krug O, Thomas A, Thevis M.
europepmc +1 more source
Real-World Selection of Venetoclax-Obinutuzumab Versus BTK Inhibitor Therapy for Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. [PDF]
Tidswell R +7 more
europepmc +1 more source

